immunotherapy

[ASAP] Cancer Immunotherapy through the Inhibition of Diacylglycerol Kinases Alpha and Zeta

ACS Medicinal Chemistry Letters
DOI: 10.1021/acsmedchemlett.0c00118




immunotherapy

Immunotherapy drug improves outcomes for some children with relapsed leukemia

For children and young adults with certain relapsed B-cell acute lymphoblastic leukemia (B-ALL), the immunotherapy drug blinatumomab is superior to standard chemotherapy, an NCI-sponsored Children’s Oncology Group trial shows.




immunotherapy

Podcast: Explaining menopause in killer whales, triggering killer mice, and the role of chromosome number in cancer immunotherapy

This week, we chat about a surprising reason why killer whales undergo menopause, flipping a kill switch in mice with lasers, and Fukushima residents who measured their own radiation exposure[link tk], with Online News Editor Catherine Matacic. Plus, Science’s Alexa Billow talks to Stephen Elledge about the relationship between chromosomal abnormalities in tumors and immunotherapy for cancer.   Listen to previous podcasts.   [Image: Copyright Kenneth Balcomb Center for Whale Research; Music: Jeffrey Cook]




immunotherapy

Lilly and Sitryx sign immunotherapy pact




immunotherapy

Dendritic cells reprogrammed by CEA messenger RNA loaded multi-functional silica nanospheres for imaging-guided cancer immunotherapy

Biomater. Sci., 2020, Advance Article
DOI: 10.1039/D0BM00395F, Communication
Yue Hu, Yuyin Tang, Xiao-Jing Zhang, Xiao-Tong Yang, Ying-Ying Tang, Su Li, Linyu Hu, Peng Chen, Dong Zhu
Multi-functional and hierarchically structured silica nanospheres are rationally designed and fabricated, which encapsulate quantum dots to permit near infrared deep tissue imaging and are loaded with carcinoembryonic antigen messenger RNA (CEAmRNA) to enable stable and abundant antigen expression in DCs.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry




immunotherapy

A biomimetic orally targeted delivery of Bindarit for immunotherapy of atherosclerosis

Biomater. Sci., 2020, Accepted Manuscript
DOI: 10.1039/D0BM00418A, Paper
Luqi Yin, Cuiping Peng, Yue Tang, Yuchuan Yuan, Jiaxing Liu, Tingting Xiang, Feila Liu, Zhou Xing, Xiaohui Li
Monocyte chemoattractant protein-1 (MCP-1) plays an important role in the development of atherosclerosis. However, the application of bindarit (a specific synthetic inhibitor of MCP-1) in atherosclerosis has not been confirmed...
The content of this RSS Feed (c) The Royal Society of Chemistry




immunotherapy

Effects of A-beta immunotherapy and Omega-3 fatty acid administration in Alzheimer's transgenic mice




immunotherapy

Lilly boosts immunotherapy pipeline with Armo BioSciences acquisition

The drug company will pay $1.6 billion to gain Armo’s IL-10 program




immunotherapy

The difficult search for the right recipe in cancer immunotherapy

With so many ingredients on hand, can the oncology community figure out how to sensibly and efficiently combine checkpoint inhibitors with other drugs?




immunotherapy

Guide to cancer immunotherapy / edited by Suzanne Walker, CRNP, MSN, AOCN, BC, Elizabeth Prechtel Dunphy, DNP, RN, CRNP, BC, AOCN